V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16625958 | 330006356 | EEI00 | 3600 | X722 | 1 | 2016-08-20 | ETOPOSIDE | 330001226 | 330003148 | 330006356 |
| 16625959 | 330006356 | EUJ01 | 200 | null | 1 | 2016-08-27 | NOT CHEMO | 330001226 | 330003148 | 330006356 |
| 16625960 | 330006358 | EPH | 800 | X724 | 2 | 2013-02-20 | IFOSFAMIDE | 330001235 | 330003150 | 330006358 |
| 16625961 | 330006361 | EEI00 | 1800 | null | 1 | 2015-01-05 | CYCLOPHOSPHAMIDE | 330001265 | 330011563 | 330006361 |
| 16625962 | 330006361 | EZ102 | 20 | X721 | 1 | 2015-01-06 | STEROID | 330001265 | 330011563 | 330006361 |
| 16625963 | 330006361 | EGU08 | 425 | X729 | 1 | 2015-01-07 | AZD9150 | 330001265 | 330011563 | 330006361 |
| 16625964 | 330006363 | EEI00 | 4800 | null | 1 | 2015-06-04 | NOT CHEMO | 330001279 | 330003154 | 330006363 |
| 16625965 | 330006363 | ERA20 | 62 | X724 | 1 | 2015-06-04 | VINCRISTINE | 330001279 | 330003154 | 330006363 |
| 16625966 | 330006363 | ED301 | 425 | null | 1 | 2015-06-04 | NOT CHEMO | 330001279 | 330003154 | 330006363 |
| 16625967 | 330006363 | ED301 | 2 | null | 1 | 2015-06-04 | TOPOTECAN | 330001279 | 330003154 | 330006363 |
| 16625968 | 330006363 | EEI00 | 1800 | null | 1 | 2015-06-04 | ETOPOSIDE | 330001279 | 330003154 | 330006363 |
| 16625969 | 330006363 | EEI00 | 4000 | X724 | 2 | 2015-06-04 | NOT CHEMO | 330001279 | 330003154 | 330006363 |
| 16625970 | 330006363 | EGU08 | 0 | X724 | 1 | 2015-06-05 | IFOSFAMIDE | 330001279 | 330003154 | 330006363 |
| 16625971 | 330006363 | ERA20 | 8 | null | 5 | 2015-06-05 | NOT CHEMO | 330001279 | 330003154 | 330006363 |
| 16625972 | 330006363 | ERA20 | 150 | X721 | 1 | 2015-06-05 | CISPLATIN | 330001279 | 330003154 | 330006363 |
| 16625973 | 330006363 | EE801 | 8 | null | 2 | 2015-06-09 | NOT CHEMO | 330001279 | 330003154 | 330006363 |
| 16625974 | 330006367 | ECL01 | 110 | null | 1 | 2015-02-16 | ETOPOSIDE | 330001311 | 330003157 | 330006367 |
| 16625975 | 330006367 | ERA20 | 1 | X292 | 1 | 2015-02-17 | VINCRISTINE | 330001311 | 330003157 | 330006367 |
| 16625976 | 330006367 | EK1EN | 170 | X721 | 1 | 2015-02-18 | CYTARABINE | 330001311 | 330003157 | 330006367 |
| 16625977 | 330006367 | EPH | 130 | X721 | 1 | 2015-02-18 | NOT CHEMO | 330001311 | 330003157 | 330006367 |
| 16625978 | 330006367 | EJR | 16 | X729 | 1 | 2015-02-25 | AVELUMAB | 330001311 | 330003157 | 330006367 |
| 16625979 | 330006367 | E0N03 | 1.05 | X724 | 1 | 2015-02-25 | CYTARABINE | 330001311 | 330003157 | 330006367 |
| 16625980 | 330006368 | EEI00 | 580 | null | 1 | 2013-10-01 | CETUXIMAB | 330001315 | 330003158 | 330006368 |
| 16625981 | 330006368 | EJRNN | 160 | null | 1 | 2013-10-01 | CYCLOPHOSPHAMIDE | 330001315 | 330003158 | 330006368 |
| 16625982 | 330006368 | EOI | 2 | X721 | 2 | 2013-10-01 | CYCLOPHOSPHAMIDE | 330001315 | 330003158 | 330006368 |
| 16625983 | 330006370 | EE813 | 5500 | x724 | 5 | 2016-11-14 | MESNA | 330001321 | 330003160 | 330006370 |
| 16625984 | 330006370 | EEI00 | 180 | X724 | 1 | 2016-11-14 | DOXORUBICIN | 330001321 | 330003160 | 330006370 |
| 16625985 | 330006370 | EEI00 | 2 | X721 | 1 | 2016-11-14 | MESNA | 330001321 | 330003160 | 330006370 |
| 16625986 | 330006371 | EE813 | 160 | null | 1 | 2015-06-03 | ETOPOSIDE | 330001321 | 330003161 | 330006371 |
| 16625987 | 330006371 | EGU08 | 114 | X292 | 5 | 2015-06-04 | METHOTREXATE | 330001321 | 330003161 | 330006371 |
| 16625988 | 330006371 | EPH | 8 | X729 | 1 | 2015-06-04 | NOT MATCHED | 330001321 | 330003161 | 330006371 |
| 16625989 | 330006371 | EPH | 1800 | null | 1 | 2015-06-05 | IFOSFAMIDE | 330001321 | 330003161 | 330006371 |
| 16625990 | 330006371 | EEI00 | 150 | null | 1 | 2015-06-05 | IFOSFAMIDE | 330001321 | 330003161 | 330006371 |
| 16625991 | 330006371 | EEI00 | 3.5 | X292 | 2 | 2015-06-06 | VINCRISTINE | 330001321 | 330003161 | 330006371 |
| 16625992 | 330006371 | EEI00 | 2560 | X724 | null | 2015-06-06 | IFOSFAMIDE | 330001321 | 330003161 | 330006371 |
| 16625993 | 330006371 | EOI | 1300 | null | 1 | 2015-06-06 | FLUOROURACIL | 330001321 | 330003161 | 330006371 |
| 16625994 | 330006372 | Haqrsvarq | 180 | N/A | 1 | 2016-08-23 | TOPOTECAN | 330001321 | 330003161 | 330006372 |
| 16625995 | 330006372 | ED301 | 600 | X724 | 1 | 2016-08-24 | MULTIPLE | 330001321 | 330003161 | 330006372 |
| 16625996 | 330006375 | EEI00 | 1800 | X292 | 1 | 2015-09-16 | CARBOPLATIN | 330001352 | 330003162 | 330006375 |
| 16625997 | 330006377 | E1UZ0 | 26 | null | 1 | 2016-06-09 | ETOPOSIDE | 330001359 | 330003163 | 330006377 |
| 16625998 | 330006377 | EQM | 1350 | x724 | 5 | 2016-06-09 | CYTARABINE | 330001359 | 330003163 | 330006377 |
| 16625999 | 330006377 | EOF | 3600 | X721 | 1 | 2016-06-09 | RITUXIMAB | 330001359 | 330003163 | 330006377 |
| 16626000 | 330006379 | ECL02 | 37.5 | X729 | 2 | 2014-07-10 | IFOSFAMIDE | 330001374 | 330003165 | 330006379 |
| 16626004 | 330006385 | EGU08 | 1160 | null | 1 | 2016-12-13 | CYTARABINE | 330001399 | 330003170 | 330006385 |
| 16626005 | 330006385 | EEI00 | 125 | null | 1 | 2016-12-13 | CYTARABINE | 330001399 | 330003170 | 330006385 |
| 16626006 | 330006385 | EK1EN | 4560 | X724 | 5 | 2016-12-13 | CYTARABINE | 330001399 | 330003170 | 330006385 |
| 16626007 | 330006385 | ECL02 | 440 | X721 | 1 | 2016-12-13 | IFOSFAMIDE | 330001399 | 330003170 | 330006385 |
| 16626008 | 330006385 | EEI00 | 150 | null | 1 | 2016-12-13 | AZD9150 | 330001399 | 330003170 | 330006385 |
| 16626009 | 330006385 | ECL01 | 1.2 | X721 | 1 | 2016-12-20 | CETUXIMAB | 330001399 | 330003170 | 330006385 |
| 16626010 | 330006386 | EEI00 | 3.5 | null | 1 | 2016-11-26 | AZD9150 | 330001399 | 330003170 | 330006386 |